News
On the Frontier of LLLT
Published Wednesday, August 18, 2010Physican uses LLLT to treat neuropathic pain
2010 American Academy of Pain Management
Published Friday, August 13, 2010Microlight will attend the 2010 American Academy of Pain Management meeting and exhibit “Cold Lasers” used for treating fibromyalgia and myofascial pain.
Also, Benard Filner, M.D., who has published a book about his experience using Microlight Lasers to treat these conditions, will be available to answer questions.
Date: September 21-24, 2010
Location: Las Vegas, Nevada
For more information contact:
shelia@aapainmanage.org
Events 2010
Published Saturday, July 31, 2010Mike Barbour, President and Founder of MicroLight Corporation of America has many conference presentations scheduled in 2010. Check back frequently to see what’s coming up!
IndeFree Conference Series
Location: Newport Beach, CA
Date: August 27-28
Location: Chicago, IL
Date: September 24-25
Contact 800-801-4511 for additional information.
Doctor Mitch Mally
Location: Chicago, IL
Date: August 7
Location: Dallas, TX
Date: September 24-26
For more information about Dr. Mitch Mally’s events, please call 563-343-0394.
MicroLight in the News!
Published Friday, July 02, 2010Click here to read a news brief about a study showing that the use of low level laser therapy reduced post operative downtime, pain and scarring among cosmetic surgery patients.
Unauthorized MicroLight Dealers
Published Saturday, May 01, 2010Purchasers of the company’s ML830© laser units from unauthorized sources should be aware that the company may not provide warranty repairs on the ML830© units they purchased. Here is a list of the entities we recently learned are falsely claiming to be dealers for the ML830©, but who really have no official affiliation with MicroLight nor are authorized to sell to the public:
Amazon
Break Through Technology Corporation
Chirocity
Docstore
Ebay
HBL Enterprises
Laser Therapeutics
Massage Warehouse
MedexSupply
MedicalSuppliest
Newlifesystems
Promed Products
Providence
Quantum-Healing-Lasers
ScripHessco
Shopping.com
Plus, any other discount seller on eBay or any similar auction website.
If other unauthorized sellers appear, we will do our best to keep the public informed of the situation.
For a more complete explanation of why these purchases may be unlawful and why the MicroLight Corporation of America may refrain from providing any warranty, click here.
Laser Treats Fibromyalgia
Published Sunday, April 18, 2010Press Release: LASER TREATS FIBROMYALGIA
MICROLIGHT CORP.OF AMERICA
Rockville, MD
April 19, 2010
Fibromyalgia is a condition in which the brain processes pain in an abnormal way, resulting in chronic, widespread muscular-skeletal pain and chronic fatigue. This condition effects millions of Americans and has been poorly understood and under diagnosed, resulting in billions of dollars in cost to our health care system. In the past, treatments have been primarily with medications; often side effects can make the symptoms worse.
The LOW LEVEL LASER used is the Patented ML830® which was the first “low level Laser” approved by the FDA in 2002 to treat pain and swelling. The Laser produces no heat to the tissue and causes vassal dilation in the Micro Capillary bed, the treatment is PAINLESS WITH NO SIDE EFFECTS. Bernard Filner M.D. is now reporting on treating over 90,000 Fibro Trigger Points using the ML830® Laser with a 90% success rate.
Bernard Filner, M.D. reports his clinical success in the use of LOW LEVEL LASER THERAPY to treat FIBROMYALGIA SYNDROME (FMS) in the April issue of Fibromyalgia Aware (the quarterly journal of the National Fibromyalgia Association) Dr. Filner sits on the National Advisory Board of the National Fibromyalgia Association. Dr. Filner has been in the forefront of the practice of Pain Management for the past 22 years, (specializing in the treatment of MYOFASCIAL PAIN and FIBROMYALGIA) and an anesthesiologist for the prior 18 years (CV available upon request).
Links www.thepaincenter.com, www.microlightcorp.com, or www.microlightlasersales.com
Contact: Steve Barbour
713-927-7068
Adverse Event Report Filed for Anodyne
Published Saturday, April 17, 2010January 9, 2010: An adverse event report regarding Anodyne Therapy was filed with the FDA.
To see the report, click here.
Bernard Filner, M.D. speaks on myofascial pain at NAMTPT Conference
Published Monday, April 12, 2010NAMTPT Conference
Date: June 23-25, 2010
Location: Chicago, IL
Attend the conference to hear Bernard Filner, M.D. speak on myofascial pain.
For more information, click www.myofascialtherapy.org.
MicroLight exhibit at Logan College of Chiropractic
Published Monday, April 12, 2010MicroLight will exhibit at the Logan College of Chiropractic in Chesterfield, MO, during Homecoming 2010: Imagine What We Will Do Next!
June 10-12, 2010.
For more information about the event, click here.
FDA warns BTL Industries, Inc.
Published Wednesday, April 07, 2010March 12, 2010: FDA issued BTL Industries, Inc. a warning for marketing in the U.S. infrared lamp devices without FDA clearance or approval.
Click here to read the FDA’s warning letter to BTL Industries, Inc.
MicroLight Pres and Founder guest speaker at conferences Spring 2010
Published Monday, March 15, 2010Mike Barbour is scheduled to speak at the following conferences:
Date: April 10
Location: Palmer Chiro School, San Jose, CA
Date: April 15
Location: Andrews University PT School, Berrien Springs, MI
Date: May 29
Location: IndeFree meeting, Houston, TX
Development of the Diode Laser System
Published Saturday, February 13, 2010Abstracted from the work of T. Oshiro in Low-Reactive Level Laser Therapy – Practical Applications, 1991.
Oshiro explains how early diode lasers were made of gallium arsenide (GaAs), a material that usually produced a beam at 904 nm which was difficult to operate for long periods of time because the diode had a tendency to overheat.
Beginning in 1979, however, experiments were carried out with a new type of diode made of gallium aluminum arsenide (GaAlAs) from which a variety of wavelengths ranging from 720 to 904 mn could be operated in a continuous wave without overheating.
It was learned from the data that there is an optimum wavelength for GaAlAs diodes to be used on human tissue at between 820 and 840 nm because of low water absorption rates in that wavelength zone.
Further wavelength experimentation showed a peak penetration effect at 820-840 mn with a corresponding therapeutic effectiveness of laser beams within that waveband. Experiments also showed that power levels of more than 60 mW per laser diode do not increase effectiveness and add the potential for some undesirable side-effects such as exacerbation of the pain, involuntary muscular spasms, and nerve syncope.
Oshiro reports that a battery-powered hand-held 15mW 830 nm continuous wave “system” containing a GaAlAs diode was first introduced at an international congress known as “Laser Tokyo ’81.”
Article by Dr. Paul J. Silbert Featuring ML830®
Published Saturday, February 13, 2010Read Dr. Silbert’s article featuring the ML830®, published by Meridian HealthViews Magazine. To view the article “Surgery-Free Treatment for Carpal Tunnel Syndrome,” click here.
FDA Warns about buying lasers on the web
Published Saturday, February 13, 2010The FDA warns the public to avoid buying laser devices on the internet because those devices may not have proper FDA clearance for sale. For more information about the FDA’s position click here.
MicroLight Corporation of America acknowledges its FDA obligation to monitor the sale of ML830© units through authorized dealers. While complying with FDA rules and regulations, MicroLight may not provide warranty service for ML830© units purchased from unauthorized sources. (ML830© units purchased from authorized dealers enjoy 100% parts and labor warranty [excluding mishandling] for one year after the dealer’s purchase date.)
All MicroLight ML830© laser units are serially numbered when they leave our factory, as required by the FDA, and all ML830© units are sold only under prescription from licensed clinicians, also an FDA requirement. (Prescriptions are required because of the Class IIIb standing of the ML830© unit, as opposed to the Class IIIa designation of the competitors’ lower-power “laser pointer” devices.) MicroLight meets its FDA obligations under the FDA regulations by tracing the marketplace entry and legitimate ownership of all genuine ML830© units.
There are reports that counterfeit or “knockoff” ML830© lasers are offered for sale on the internet. MicroLight urges suspicious or cautious prospective purchasers to contact MicroLight through Contact Us to ensure that those who offer the ML830© are in fact authorized dealers. But, for example, you may be assured that no authorized MicroLight dealer sells the ML830© through eBay, because of the buyer’s need to show a prescription from a licensed clinician at the time of ML830© purchase.
In summary, MicroLight warns prospective purchasers to beware of the situation and protect themselves from unauthorized dealers by avoiding discount sellers, including any that may appear on eBay, because of the risk that the genuine article may not be what is purchased and because of the lack of product warranty that may result from the purchase of an ML830© from any unauthorized person or entity.
ML830® vs. STIM, Ultrsound
Published Saturday, February 13, 2010Product Comparison
ML830® vs. STIM and Ultrasound
The status quo in injury recovery involves ice, heat, and electronic stimulation in some form, primarily
TENS (transcutaneous electrical nerve stimulators) and rehab.